Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$1.26 -3.82%
Market Cap
$71.3M
Price Target
Refer to Report
Volume
132.2K
52wk Range
$0.6101 - $5.53
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.